Physician profile
Cory Daniel Jackson
NPI 1609365170
$6,811.44
in general payments reported to CMS, 2019-2025
9 companies · $406 in 2025
The $406 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $104 · 2023: $134 · 2024: $6,168 · 2025: $406.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $6,000 · Food and Beverage: $708.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $6,000.00 |
| Food and Beverage | $707.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $6,000.00 | 2024 | |
| Boston Scientific Corporation | $302.25 | 2023-2024 | Rotablator Rotational Atherectomy System Console Kit, Opticross |
| Abbott Laboratories | $207.55 | 2025 | Optis, Coroflow |
| Teleflex LLC | $103.55 | 2022 | |
| Abiomed | $84.04 | 2025 | |
| Shockwave Medical, INC | $45.54 | 2025 | |
| Novo Nordisk INC | $29.68 | 2025 | Wegovy |
| Cordis US Corp. | $23.03 | 2025 | Mynx Control Venous |
| Stryker Corporation | $15.80 | 2025 | Flowtriever |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cory Jackson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.